MetaCap

QT Imaging (QTI) vs Valion Bio (VBIO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

QT Imaging is the larger company by market cap ($37.6 million vs $1.9 million), about 19.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

QTI versus VBIO key metrics
MetricQTIVBIO
Share price$2.57$2.19
Market cap$37.62M$1.94M
1-day change-0.39%-7.98%
YTD return-57.87%—
1-year return-92.29%—
EPS (TTM)$-1.40$-161.21
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$36.75$78.75
52-week low$2.42$2.05
Distance from 52-week high-93.01%-97.22%
Average volume34.09K1.46M
Shares outstanding14.64M887.59K
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • QT Imaging is about 19.4 times larger than Valion Bio by market value ($37.62M vs $1.94M).

QTI vs VBIO FAQ

Which is bigger, QT Imaging or Valion Bio?

QT Imaging (QTI) is larger, with a market capitalization of $37.62M compared with $1.94M for Valion Bio (VBIO).

Are QT Imaging and Valion Bio in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons